Li, Chiang J.,Li, Youzhi,Gao, Yuan,Wang, Yuxin,Huang, Janet,Rogoff, Harry
申请号：
AU2016271475
公开号：
AU2016271475A1
申请日:
2016.06.03
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Disclosed herein are methods for use in treating cancer comprising administering at least one cancer sternness inhibitor, for example, at least one STAT3 pathway inhibitor such as 2-acetylnaphtho [2, 3 -b] furan-4, 9-dione, in order to sensitize or re-sensitive a cancer that is naive, resistant, or/and refractory to at least one immunotherapeutic agent, such as at least one immune checkpoint modulator.
